look at study NCT01687257
Hopeful, I thought I recall that you have portal hypertension and your doctor said your liver was too damaged for triple TX. Doesn't that mean that your liver is decompensated and would not meet the criteria for the ABT trial?
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis. (TURQUOISE-II)
The purpose of this study is to evaluate the safety and effect of ABT-450, ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 coadministered with ribavirin (RBV) in HCV genotype 1-infected adults with compensated cirrhosis. (TURQUOISE-II)
For more info on the trial follow the below link
http://clinicaltrials.gov/ct2/show/NCT01704755?term=ABT+M13-099&rank=1